Shire Pharmaceuticals
Shire Pharmaceuticals (United States) has no DMF, CEP or site registration linked in our records. 1 FDA enforcement record is linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Shire Pharmaceuticals: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/shire-pharmaceuticals
Overview
Shire Pharmaceuticals, now a subsidiary of Takeda Pharmaceutical Company, was a global biopharmaceutical company focused on serving people with rare diseases and other highly specialized conditions. After its acquisition in 2019, Shire's operations have been integrated into Takeda's broader pharmaceutical operations.
Therapeutic areas
FDA compliance signals
1 FDA enforcement record linked to this company.
- warning_letter2009-11-05
FDA Warning Letter (drug product)
Is this Shire Pharmaceuticals?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Related companies
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.